Factors affecting the clearance of psoriasis with dithranol (anthralin).
D000873:Anthracenes / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use; D002725:Chloroform / Q000627:therapeutic use; D003116:Color; D006801:Humans; D009824:Ointments; D010087:Oxides / Q000627:therapeutic use; D010232:Paraffin / Q000627:therapeutic use; D010592:Pharmaceutic Aids; D011565:Psoriasis / Q000188:drug therapy*; D012459:Salicylates / Q000627:therapeutic use; D012996:Solutions; D013213:Starch / Q000627:therapeutic use; D015032:Zinc / Q000627:therapeutic use
D000873:Anthracenes; D001565:Benzoates; D009824:Ointments; D010087:Oxides; D010592:Pharmaceutic Aids; D012459:Salicylates; D012996:Solutions; D002725:Chloroform; D010232:Paraffin; D013213:Starch; D015032:Zinc